Clyde Biosciences

Clyde Biosciences is a contract research organisation specialising in human cardiomyocyte assays for cardiac drug safety and efficacy.

Its optical platform measures membrane voltage, calcium dynamics and contraction in induced pluripotent stem cell-derived cardiomyocytes within a single experiment, generating mechanistic data on arrhythmia risk and drug-related contractile effects.

Its services support compound screening, safety pharmacology and cardiovascular drug discovery, using human-relevant in vitro models to reduce reliance on animal testing.